A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up.

Cather, Jennifer; Young, Melodie; DiRuggiero, Douglas C; Tofte, Susan; Williams, Linda; Gonzalez, Tayler

Cather, Jennifer; Young, Melodie; DiRuggiero, Douglas C; Tofte, Susan; Williams, Linda; Gonzalez, Tayler.

Afiliação

Cather J; Mindful Dermatology and Modern Research Associates, Dallas, TX, USA.
Young M; Mindful Dermatology and Modern Research Associates, Dallas, TX, USA.
DiRuggiero DC; Skin Cancer and Cosmetic Dermatology Center, Rome, GA, USA.
Tofte S; Oregon Health and Science University, Portland, OR, USA.
Williams L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Gonzalez T; Sanofi, Cambridge, MA, USA. Tayler.Gonzalez@sanofi.com.

Dermatol Ther (Heidelb) ; 12(9): 2013-2038, 2022 Sep.

Article em En | MEDLINE | ID: mdl-36028787

Palavras-chave

Adolescents; Adults; Atopic dermatitis; Children; Dupilumab; Efficacy; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google